SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-23-011248
Filing Date
2023-03-23
Accepted
2023-03-23 20:40:46
Documents
1
Period of Report
2023-03-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1341
  Complete submission text file 0001127602-23-011248.txt   2696
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Issuer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 PLACE D ARMES SUITE 1800 MONTREAL A8 H2Y 2W2
Business Address
Theagene Jean-Manasse (Reporting) CIK: 0001969857 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41455 | Film No.: 23757512